Dr. Usha Anand, MD (she/her) is a Internist in Marietta, GA with over 18 years of experience. What is your opinion of Dr. Usha Anand, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Usha Anand, MD has received over $1,819 which includes payments from the following companies:
$546.37 from Janssen Pharmaceuticals, Inc
$228.64 from Novartis Pharmaceuticals Corporation
$188.24 from Merck Sharp & Dohme Corporation
$134.42 from Otsuka America Pharmaceutical, Inc.
$115.59 from E.R. Squibb & Sons, L.L.C.
$76.24 from The Medicines Company
$64.81 from Salix Pharmaceuticals, a division of Bausch Health US, LLC
$57.39 from Actavis Pharma Inc
$48.43 from Melinta Therapeutics, Inc.
$33.12 from sanofi-aventis U.S. LLC
$32.42 from AstraZeneca Pharmaceuticals LP
$29.13 from Medtronic Sofamor Danek USA, Inc.
$22.70 from Astellas Pharma US Inc
$22.05 from Mallinckrodt LLC
$21.40 from Sunovion Pharmaceuticals Inc.
$20.95 from Bayer HealthCare Pharmaceuticals Inc.
$19.48 from Valeant Pharmaceuticals North America LLC
$18.99 from PORTOLA PHARMACEUTICALS, INC.
$18.17 from Gilead Sciences Inc
$17.94 from Allergan Inc.
Payments received by Dr. Usha Anand, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!